Drug development in pulmonary hypertension: new approaches to gather knowledge

Watch the replay

Agenda

Lisa Lavange // The use of master protocols and a platform design: lessons from COVID-19 therapeutic trials
Panel discussion // A platform trial and master protocol for PAH clinical trials: is it feasible, and if so, which drugs do we want to study?
Stephen Mathai // The use of RWD/RWE in bringing drugs to PH patients
Panel discussion // RWD/RWE in PH: what are the questions and can we get the answers?

Sign up for news

Email address*

The PVRI requests your permission to record and use the personal information provided.

We will use your data to add you to the ‘Membership Directory’ to enable networking amongst like-minded professionals and achieve the wider goals of the PVRI, in line with our ‘Membership Agreement’ and ‘Legitimate Interests’. This directory is accessible only by other members and employees of the PVRI. Some data processing is carried out by third party suppliers, details of which can be found in our ‘Privacy Notice’ .

You can refuse or withdraw your consent at any time without detriment to your membership. You can do this by emailing admin@pvrinstitute.org.

If the purpose for which we wish to use your data or the way in which we use personal data change, we will contact you to renew consent.

Please tick here to confirm your consent to the activities listed above.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI

Watch the replay

Agenda

Related Content

{{GlobalController.truncateTitle("Professor Sheila Glennis Haworth Memorial Symposium on Paediatric PH", 65)}}

{{GlobalController.truncateTitle("The association between cancer and PH: A tale of two diseases", 65)}}

{{GlobalController.truncateTitle("Pulmonary hypertension community call - April 2022", 65)}}

{{GlobalController.truncateTitle("Pulmonary hypertension community call - March 2022", 65)}}

{{GlobalController.truncateTitle("Ageing and pulmonary hypertension: an endemic at the horizon?", 65)}}

Add to reading list

Share this content

Our research platform is the world.